At Overlook’s Institute for Rheumatic and Autoimmune Diseases (IRAD), three physician volunteers bring valuable insight into the diagnosis, treatment, and development of therapeutics for chronic disorders that are often undiagnosed or misdiagnosed.
“These experienced rheumatologists dedicate several hours per month to our program and patients outside of their full-time positions,” comments Neil Kramer, MD, co-director of IRAD with Elliot D. Rosenstein, MD.
“There is a long history of physicians in research and the pharmaceutical industry volunteering time to maintain their clinical skills,” observes Dr. Rosenstein, who, along with Dr. Kramer, has decades of experience in the diagnosis and treatment of rheumatic and other inflammatory musculoskeletal diseases.
“Since 2011, we’ve provided physicians an opportunity to maintain their clinical acumen and have clinical discourse in exchange for their clinical services. They have knowledge of drugs in development and the science behind them, clinical trial design and registry data — all of which helps keep us on the cutting edge of patient care.”
IRAD is the only hospital-based institute of its kind in New Jersey, providing a complete range of treatment options and a clinical research center with access to innovative therapies for rheumatic and autoimmune diseases.
IRAD Physician Volunteers
“Patients at IRAD have access to an academia-style hospital without going to a major university center,” observes Nikolay Delev, MD, a Johns Hopkins-trained rheumatologist who designs clinical trials for rheumatologic medications for Bristol-Myers Squibb and who has volunteered at IRAD for nine years.
“I truly value and enjoy the patient care relationship,” says Arathi Setty, MD, a Harvard-trained rheumatologist developing rheumatologic medication as senior medical director at AbbVie, a research-based global biopharmaceutical company.
“I’ve spent 20 years researching drug safety,” explains rheumatologist Jeffrey Greenberg, MD, MPH, a nine-year IRAD volunteer who trained at NYU School of Medicine and serves as chief medical officer at CorEvitas LLC, which manages clinical registries tracking long-term outcomes of patients prescribed therapeutics for autoimmune and inflammatory conditions.